ApoGen Biotechnologies
Business Services · 1-10 Employees
View Company Info for Free
Overview
Phone Number
(206) 957-7300Website
www.apogenbiotech.comRevenue
<$5 MillionIndustry
About ApoGen Biotechnologies
ApoGen Biotechnologies Org Chart
Scientific Advisor
Scientific Advisor
Scientific Advisor
Scientific Advisor
Is ApoGen Biotechnologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at ApoGen Biotechnologies
Check if ApoGen Biotechnologies has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once ApoGen Biotechnologies has new funding data
ApoGen Biotechnologies, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when ApoGen Biotechnologies launches new products
Earning: See what the market has to say on ApoGen Biotechnologies recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if ApoGen Biotechnologies is spiking on competitors!
Click to see if ApoGen Biotechnologies had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to ApoGen Biotechnologies
Compare insights from companies similar to ApoGen Biotechnologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ApoGen Biotechnologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ApoGen Biotechnologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ApoGen Biotechnologies.
ApoGen Biotechnologies financials insights
Gather financial insights about ApoGen Biotechnologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$11M
ApoGen Biotechnologies Tech Stack
A closer look at the technologies used by ApoGen Biotechnologies
ApoGen Biotechnologies News & Media
ApoGen Biotechnologies Expands Series A Financing to $11 Million and Enhances Leadership Team
SEATTLE--(BUSINESS WIRE)--ApoGen Biotechnologies, Inc., a company developing a new class of drugs that target the underlying mechanisms that lead to the development of drug resistance by cancer cells, today announced the expansion of its Series A financing to a total of $11 million. M Ventures, the strategic, corporate venture arm of Merck KGaA, Darmstadt, Germany, and existing investors provided an additional $4 million in the company’s Series A. Concurrent with the financing, Keno Gutierrez,
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ApoGen Biotechnologies
ApoGen Biotechnologies, Inc. is focused on developing a new class of therapies aimed at overcoming drug resistance in cancer by targeting key drivers of DNA mutation and tumor evolution. The company leverages innovative technologies, including blockchain, to enhance data security and patient engagement in the healthcare sector. Their solutions aim... Read More